Vbi Vaccines Stock Today
| VBIVQ Stock | 0.0005 0.0001 16.67% |
Performance0 of 100
| Odds Of DistressOver 88
|
VBI Vaccines is selling at 5.0E-4 as of the 25th of December 2024; that is 16.67% down since the beginning of the trading day. The stock's last reported lowest price was 5.0E-4. VBI Vaccines has a very high chance of experiencing financial distress in the next few years of operation. It has also generated negative returns for investors over the last 90 days. The performance scores are derived for the period starting the 28th of June 2024 and ending today, the 25th of December 2024. Click here to learn more.
Category Healthcare |
VBI Vaccines is entity of United States. It is traded as Stock on NASDAQ exchange. More on VBI Vaccines
Moving together with VBI Stock
Moving against VBI Stock
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
VBI Stock Highlights
| CEO President | Jeffery FCMA | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Biotechnology, Healthcare, Biotechnology, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial Strength
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
VBI Vaccines can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand VBI Vaccines' financial leverage. It provides some insight into what part of VBI Vaccines' total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
VBI Vaccines (VBIVQ) is traded on NASDAQ Exchange in USA and employs 131 people. The company classifies itself under Healthcare sector and is part of Biotechnology industry.
VBI Vaccines generates negative cash flow from operations
Check VBI Vaccines Probability Of Bankruptcy
VBI Vaccines Risk Profiles
Investors will always prefer to have the highest possible return on investment while minimizing volatility. VBI Vaccines market risk premium is the additional return an investor will receive from holding VBI Vaccines long position in a well-diversified portfolio.
| Mean Deviation | 14.22 | |||
| Standard Deviation | 29.43 | |||
| Variance | 865.83 | |||
| Risk Adjusted Performance | (0.04) |
VBI Stock Against Markets
VBI Vaccines Corporate Management
| FRCPC MD | Chief Officer | Profile | |
| Avi Mazaltov | Global SciVac | Profile | |
| Misha Nossov | Senior Europe | Profile | |
| David Anderson | Chief Officer | Profile |
Additional Tools for VBI Stock Analysis
When running VBI Vaccines' price analysis, check to measure VBI Vaccines' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy VBI Vaccines is operating at the current time. Most of VBI Vaccines' value examination focuses on studying past and present price action to predict the probability of VBI Vaccines' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move VBI Vaccines' price. Additionally, you may evaluate how the addition of VBI Vaccines to your portfolios can decrease your overall portfolio volatility.